XML 39 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restructuring Charges
9 Months Ended
Sep. 30, 2013
Restructuring Charges
9. RESTRUCTURING CHARGES

In February 2012, the Company realigned its business structure and implemented a number of strategic and operational initiatives.  As part of these initiatives, the Company terminated certain early stage, preclinical research and development programs and a workforce reduction was implemented.  As a result of the restructuring, during the nine months ended September 30, 2012, the Company recorded one-time charges of approximately $1.4 million, which included severance and benefits related charges of approximately $1.2 million, outplacement costs of approximately $120,000, stock compensation expense of $56,000 for amendments to the exercise schedules to certain options, and other exit costs of $90,000.  All restructuring costs were paid during 2012.